• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Outcomes after extracorporeal life support for COVID-19 myocarditis: an analysis of the Extracorporeal Life Support Organization Registry.COVID-19心肌炎体外膜肺氧合治疗的预后：体外膜肺氧合组织注册研究分析
Crit Care. 2022 Aug 3;26(1):235. doi: 10.1186/s13054-022-04111-z.
2
Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry.体外膜肺氧合支持婴幼儿和青少年暴发性心肌炎患者：体外生命支持组织登记的回顾。
Crit Care Med. 2010 Feb;38(2):382-7. doi: 10.1097/CCM.0b013e3181bc8293.
3
Extracorporeal membrane oxygenation for the support of adults with acute myocarditis.体外膜肺氧合支持成人急性心肌炎。
Crit Care Med. 2015 May;43(5):1016-25. doi: 10.1097/CCM.0000000000000920.
4
Outcomes after prolonged extracorporeal membrane oxygenation support in children with cardiac disease--Extracorporeal Life Support Organization registry study.儿童心脏病患者长时间体外膜肺氧合支持后的结局——体外生命支持组织登记研究。
J Thorac Cardiovasc Surg. 2014 Aug;148(2):582-8. doi: 10.1016/j.jtcvs.2013.09.038. Epub 2013 Nov 1.
5
Development and Validation of a Score to Predict Mortality in Children Undergoing Extracorporeal Membrane Oxygenation for Respiratory Failure: Pediatric Pulmonary Rescue With Extracorporeal Membrane Oxygenation Prediction Score.用于预测呼吸衰竭患儿体外膜肺氧合治疗死亡率的评分系统的开发与验证：体外膜肺氧合预测评分的儿科肺脏救援
Crit Care Med. 2017 Jan;45(1):e58-e66. doi: 10.1097/CCM.0000000000002019.
6
Pregnant and Peripartum Women with COVID-19 Have High Survival with Extracorporeal Membrane Oxygenation: An Extracorporeal Life Support Organization Registry Analysis.患有新冠肺炎的孕妇和围产期妇女接受体外膜肺氧合治疗后生存率较高：体外生命支持组织注册分析
Am J Respir Crit Care Med. 2022 Jan 15;205(2):248-250. doi: 10.1164/rccm.202109-2096LE.
7
Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry.COVID-19 患者的体外膜肺氧合治疗：国际体外生命支持组织注册研究的结果演变。
Lancet. 2021 Oct 2;398(10307):1230-1238. doi: 10.1016/S0140-6736(21)01960-7. Epub 2021 Sep 29.
8
The impact of mechanical ventilation time before initiation of extracorporeal life support on survival in pediatric respiratory failure: a review of the Extracorporeal Life Support Registry.体外生命支持开始前机械通气时间对小儿呼吸衰竭患者生存的影响：对体外生命支持登记处的回顾。
Pediatr Crit Care Med. 2012 Jan;13(1):16-21. doi: 10.1097/PCC.0b013e3182192c66.
9
Neurologic Injury in Adults Supported With Veno-Venous Extracorporeal Membrane Oxygenation for Respiratory Failure: Findings From the Extracorporeal Life Support Organization Database.体外膜肺氧合治疗呼吸衰竭成人的神经损伤：体外生命支持组织数据库的研究结果。
Crit Care Med. 2017 Aug;45(8):1389-1397. doi: 10.1097/CCM.0000000000002502.
10
Hemoadsorption in cardiac shock with bi ventricular failure and giant-cell myocarditis: A case report.双心室衰竭和巨细胞性心肌炎所致心源性休克的血液吸附：一例报告
Int J Artif Organs. 2018 Aug;41(8):474-479. doi: 10.1177/0391398818777362. Epub 2018 May 30.

引用本文的文献

1
Mechanical Circulatory Support Systems in Fulminant Myocarditis: Recent Advances and Outlook.暴发性心肌炎中的机械循环支持系统：最新进展与展望
J Clin Med. 2024 Feb 20;13(5):1197. doi: 10.3390/jcm13051197.
2
COVID-19 fulminant myocarditis recovered with veno-arterial extracorporeal membrane oxygenation and Impella CP.新冠病毒感染所致暴发性心肌炎经静脉-动脉体外膜肺氧合及Impella CP治疗后康复。
J Cardiol Cases. 2023 May 10;28(3):116-9. doi: 10.1016/j.jccase.2023.05.003.
3
Extracorporeal Membrane Oxygenation in Acute Respiratory Failure.急性呼吸衰竭中的体外膜肺氧合
Pulm Ther. 2023 Mar;9(1):109-126. doi: 10.1007/s41030-023-00214-2. Epub 2023 Jan 21.
4
Timing of tracheostomy and patient outcomes in critically ill patients requiring extracorporeal membrane oxygenation: a single-center retrospective observational study.需要体外膜肺氧合的危重症患者气管切开的时机与患者预后：一项单中心回顾性观察研究
J Intensive Care. 2022 Dec 30;10(1):56. doi: 10.1186/s40560-022-00649-w.
5
What is New in ECMO for COVID-19?用于治疗新冠肺炎的体外膜肺氧合（ECMO）有哪些新进展？
J Cardiothorac Vasc Anesth. 2023 Feb;37(2):331-334. doi: 10.1053/j.jvca.2022.10.030. Epub 2022 Nov 3.

本文引用的文献

1
Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry.COVID-19 患者的体外膜肺氧合治疗：国际体外生命支持组织注册研究的结果演变。
Lancet. 2021 Oct 2;398(10307):1230-1238. doi: 10.1016/S0140-6736(21)01960-7. Epub 2021 Sep 29.
2
Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.4244 例危重症 COVID-19 成年患者的临床特征和第 90 天结局：一项前瞻性队列研究。
Intensive Care Med. 2021 Jan;47(1):60-73. doi: 10.1007/s00134-020-06294-x. Epub 2020 Oct 29.
3
COVID-19 "Fulminant Myocarditis" Successfully Treated With Temporary Mechanical Circulatory Support.新冠病毒肺炎“暴发性心肌炎”经临时机械循环支持治疗成功治愈
JACC Cardiovasc Imaging. 2020 Nov;13(11):2457-2459. doi: 10.1016/j.jcmg.2020.05.003. Epub 2020 May 11.

Outcomes after extracorporeal life support for COVID-19 myocarditis: an analysis of the Extracorporeal Life Support Organization Registry.

作者信息

Tonna Joseph E, Tan Chuen Seng, Hryniewicz Kasia, Barbaro Ryan P, Brodie Daniel, MacLaren Graeme

机构信息

The University of Utah School of Medicine, 30 N 1900 E, 3C127, Salt Lake City, UT, 84132, USA.

National University of Singapore, Singapore, Singapore.

出版信息

Crit Care. 2022 Aug 3;26(1):235. doi: 10.1186/s13054-022-04111-z.

DOI:10.1186/s13054-022-04111-z
PMID:35922832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9346058/
Abstract
摘要